Hero Image
30 November 2021 - 1 December 2021
India
UK-India Virtual Biopharmaceutical Mission 2021

Origin Pharma Packaging

Origin design, manufacture and deliver innovative pharmaceutical & healthcare packaging and device solutions. Origin group combines excellence in packaging design and manufacturing expertise across multiple disciplines with an enduring attention to supply chain efficiencies. 

About us

Origin Pharma Packaging was established over 55 years ago and now operate globally from our dedicated Pharmaceutical Packaging, Logistics & Innovation Centre. We engage in the design, manufacture and consolidated supply of pharmaceutical packaging, partnering with licence holders and CMOs.



The critical outcomes of a compliant and effective packaging continually remind us of the importance of a consistent and integrated approach to our work. As a sponsor of the pharmaceutical supply chain, complementing the colossal impact of Life Science companies worldwide, our close relationship with drug manufacturers, healthcare institutions and consumers alike gives perpetual clarity to our key deliverables.


When delivering each healthcare packaging project - whether a new product development or a bespoke supply chain solution - our proposals concentrate on innovation, assurance of supply, quality, cost, and flexibility, all key attributes of the solution our clients deserve.

Highlights

  • Origin launched the most innovative pharmaceutical business model, within the industry in 2016 - 
  • Hybrid Pharma Packaging Partner (HP³) is a change programme designed to accelerate the competitiveness of the pharmaceutical primary packaging industry by raising the performance of its supply chains. International competition, together with the challenges posed by international government legislation, necessitates rapid improvement in the effectiveness of the industry’s supply chain.

Website | https://www.originltd.com

Schedule a 1:1 business networking meeting with Origin Pharma Packaging

Location
India
Organised by
Meetings
Participants 62
Meetings 60
Participants
India 43
United Kingdom 19
United States 1
Total 63
Participants
India Biopharmaceutical/Life Science Industry 28
CDMO/CRO 10
Authority/Government 8
UK Biopharmaceutical/Life Science Industry 7
Pharma Service Provider 3
UK Nutraceutical Industry 3
Indian Nutraceutical Industry 2
R&D Institution 1
Investor/Venture Capital 1
Total 63